For research use only. Not for therapeutic Use.
BQ-788 Sodium Salt (Cat.No:I001981) is a selective antagonist of endothelin type B (ETB) receptors. It has a high affinity for ETB receptors with an IC50 of 1.2 nM. BQ-788 Sodium Salt has been used in various studies to investigate the role of ETB receptors in cardiovascular and renal systems. It has been shown to have potential therapeutic effects in diseases such as hypertension and chronic kidney disease.
Catalog Number | I001981 |
CAS Number | 156161-89-6 |
Synonyms | N-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-D-norleucine, monosodium salt |
Molecular Formula | C₃₄H₅₀N₅O₇Na |
Purity | ≥95% |
Target | Endothelin Receptor |
Solubility | DMSO: ≥ 43 mg/mL |
Storage | Store at -20°C |
IC50 | 1.2 nM |
IUPAC Name | sodium;(2R)-2-[[(2R)-2-[[(2S)-2-[[(2R,6S)-2,6-dimethylpiperidine-1-carbonyl]amino]-4,4-dimethylpentanoyl]amino]-3-(1-methoxycarbonylindol-3-yl)propanoyl]amino]hexanoate |
InChI | InChI=1S/C34H51N5O7.Na/c1-8-9-16-25(31(42)43)35-29(40)26(18-23-20-38(33(45)46-7)28-17-11-10-15-24(23)28)36-30(41)27(19-34(4,5)6)37-32(44)39-21(2)13-12-14-22(39)3;/h10-11,15,17,20-22,25-27H,8-9,12-14,16,18-19H2,1-7H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43);/q |
InChIKey | QCVIFBRTTLMEOV-FUKQNADPSA-M |
SMILES | CCCCC(C(=O)[O-])NC(=O)C(CC1=CN(C2=CC=CC=C21)C(=O)OC)NC(=O)C(CC(C)(C)C)NC(=O)N3C(CCCC3C)C.[Na+] |
Reference | 1: Okada M, Nishikibe M. BQ-788, a selective endothelin ET(B) receptor |